Adagene Inc. (NASDAQ: ADAG) Stock Information | RedChip

Adagene Inc. (NASDAQ: ADAG) Listen to this Section


$2.33
-0.0900 ( -3.72% ) 1.7K

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Market Data


Open


$2.33

Previous close


$2.42

Volume


1.7K

Market cap


$114.44M

Day range


$2.39 - $2.59

52 week range


$1.10 - $4.38

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 78 Jul 25, 2024
6-k Quarterly Reports 4 Mar 29, 2024
20-f Annual reports 115 Mar 29, 2024
6-k Quarterly Reports 6 Mar 29, 2024
6-k Quarterly Reports 29 Feb 09, 2024
6-k Quarterly Reports 3 Jan 16, 2024
6-k Quarterly Reports 3 Nov 03, 2023
6-k Quarterly Reports 1 Sep 29, 2023
6-k Quarterly Reports 3 Aug 31, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.